About Paul Berns
Form D filings for Mirador Therapeutics in 2024 list Paul Berns as director.
Paul Berns first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Paul Berns in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Paul Berns works with at each company, as listed on that company's latest Form D.
Mirador Therapeutics, Inc. · Form D, Apr 3, 2024
JP
Joseph Papa
Director
MM
Mark McKenna
Executive officer and director
SG
Scott Glenn
Director
KB
Kristina Burow
Director
VB
Vika Brough
Executive officer
DD
David Bonita, M.D.
Director
TA
Timothy Andrews
Secretary